Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017
07. November 2017 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release
20. September 2017 08:37 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that it has filed an Abbreviated New Drug Application (ANDA) with...
Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference
30. August 2017 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for ELI-200 at PAINWeek 2017 National...
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information
09. August 2017 16:39 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss First Quarter Financial Results on August 10, 2017
08. August 2017 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Announces Co-Development of Four Additional Products with SunGen Pharma
28. Juli 2017 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Announces New Development and License Agreement with SunGen Pharma LLC
12. Juli 2017 08:31 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., July 12, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™
07. Juli 2017 12:47 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., July 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported topline results from a pivotal bioequivalence fed study for...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information
14. Juni 2017 16:58 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 14, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results on June 15, 2017
13. Juni 2017 10:05 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 13, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...